Literature DB >> 11324904

Blood histamine levels (BHL) in infants and children with respiratory and non-respiratory diseases.

C Ponvert1, L Galoppin, J Paupe, J de Blic, M Le Bourgeois, P Scheinmann.   

Abstract

BACKGROUND: Blood histamine levels are decreased after severe allergic reactions and in various chronic diseases. AIMS: To study blood histamine levels in infants and children with acute infectious and non-infectious, non-allergic, disease.
METHODS: Blood histamine levels were investigated by a fluorometric method in infants and children admitted to hospital with bronchiolitis, non-wheezing bronchitis, acute infections of the urinary tract, skin and ear-nose-throat, gastroenteritis, or hyperthermia of unknown aetiology. Results of blood histamine levels and white blood cell counts were compared with those obtained for children recovering from benign non-infectious, non-allergic illnesses.
RESULTS: As compared with control children, white blood cell numbers were significantly increased in children with acute infections of the urinary tract, skin and ear-nose-throat, and were significantly decreased in children with gastroenteritis. Blood histamine levels were significantly lower in children with gastroenteritis and hyperthermia than in children with other diseases and control children. It was not possible to correlate blood histamine levels and the number of blood basophils.
CONCLUSIONS: BHL are significantly decreased in infants and children with acute gastroenteritis and hyperthermia of unknown aetiology. The mechanisms responsible for the decrease in blood histamine levels in children with gastroenteritis and hyperthermia are discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11324904      PMCID: PMC1781686          DOI: 10.1080/09629350124382

Source DB:  PubMed          Journal:  Mediators Inflamm        ISSN: 0962-9351            Impact factor:   4.711


  53 in total

1.  Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus.

Authors:  R H Bui; G A Molinaro; J D Kettering; D C Heiner; D T Imagawa; J W St Geme
Journal:  J Pediatr       Date:  1987-01       Impact factor: 4.406

2.  Neutrophil chemotactic activity and histamine in atopic and nonatopic subjects after exercise-induced asthma.

Authors:  T H Lee; T Nagakura; O Cromwell; M J Brown; R Causon; A B Kay
Journal:  Am Rev Respir Dis       Date:  1984-03

3.  Plasma histamine concentrations in atopic eczema.

Authors:  J Ring
Journal:  Clin Allergy       Date:  1983-11

4.  A high-sampling-rate automated continuous-flow fluorometric technique for the analysis of nanogram levels of histamine in biological samples.

Authors:  B Lebel
Journal:  Anal Biochem       Date:  1983-08       Impact factor: 3.365

5.  The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection.

Authors:  R C Welliver; D T Wong; M Sun; E Middleton; R S Vaughan; P L Ogra
Journal:  N Engl J Med       Date:  1981-10-08       Impact factor: 91.245

6.  Respiratory syncytial virus-specific IgE responses following infection: evidence for a predominantly mucosal response.

Authors:  R C Welliver; M Sun; D Rinaldo; P L Ogra
Journal:  Pediatr Res       Date:  1985-05       Impact factor: 3.756

7.  Histamine in nasal secretions and serum may be elevated during viral respiratory tract infections.

Authors:  T F Smith; L K Remigio
Journal:  Int Arch Allergy Appl Immunol       Date:  1982

8.  Radioimmunoassay for plasma histamine: a study of false positive and false negative values.

Authors:  D Laroche; F Dubois; J L Gérard; C Lefrançois; B André; M C Vergnaud; L Dubus; H Bricard
Journal:  Br J Anaesth       Date:  1995-04       Impact factor: 9.166

9.  Increased plasma histamine concentrations after food challenges in children with atopic dermatitis.

Authors:  H A Sampson; P L Jolie
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

10.  Decreased blood histamine levels in patients with solid malignant tumours.

Authors:  C Burtin; C Noirot; J Paupe; P Scheinmann
Journal:  Br J Cancer       Date:  1983-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.